17.01.2025Current and novel biomarkers in cardiogenic shock

Biomarkers may refine the personalised management of patients with cardiogenic shock. 
In a state-of-the-art review article, published in the European Journal of Heart Failure, an international expert consortium, including Prof. Thomas F. Lüscher and Dr. Florian A. Wenzl form the CMC, provides a comprehensive overview of present and emerging biomarkers to enhance the individualised treatment of patients with cardiogenic shock.